Distribuzione geografica
Continente #
NA - Nord America 14126
EU - Europa 4105
AS - Asia 2216
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
SA - Sud America 1
Totale 20467
Nazione #
US - Stati Uniti d'America 14086
UA - Ucraina 1393
CN - Cina 1376
IT - Italia 959
DE - Germania 552
VN - Vietnam 460
IE - Irlanda 452
TR - Turchia 360
SE - Svezia 307
FI - Finlandia 249
RU - Federazione Russa 90
GB - Regno Unito 41
CA - Canada 32
FR - Francia 27
EU - Europa 16
CZ - Repubblica Ceca 10
MX - Messico 8
IN - India 7
ES - Italia 5
PL - Polonia 5
HK - Hong Kong 4
AU - Australia 3
IR - Iran 3
JP - Giappone 3
LU - Lussemburgo 3
RO - Romania 3
GR - Grecia 2
AT - Austria 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
LV - Lettonia 1
NL - Olanda 1
SG - Singapore 1
Totale 20467
Città #
Ann Arbor 4144
Wilmington 2241
Jacksonville 1724
Princeton 1625
Chandler 1475
Houston 721
Woodbridge 595
Dong Ket 459
Dublin 447
Nanjing 397
Andover 366
Izmir 358
Boardman 278
Pellezzano 263
Beijing 252
Düsseldorf 215
Mestre 203
Norwalk 142
Shenyang 131
Fairfield 129
Hebei 121
Changsha 108
Nanchang 108
Dearborn 107
Salerno 98
Jiaxing 83
Ashburn 76
Redwood City 59
Naples 58
Tianjin 53
San Diego 48
Cambridge 30
Jinan 27
Ottawa 26
Milan 18
Venezia 18
Rome 17
Dormagen 10
Guangzhou 10
Napoli 10
Fuzhou 9
Hangzhou 9
Falls Church 8
Kunming 8
Seattle 7
Taizhou 7
Bologna 6
Lanzhou 6
Nocera Inferiore 6
Zhengzhou 6
Grumo Appula 5
Hefei 5
Saint Petersburg 5
Sant'arpino 5
Santa Maria A Vico 5
Toronto 5
Wuhan 5
Indiana 4
London 4
Orange 4
Taiyuan 4
Torino 4
Caserta 3
Cesena 3
Des Moines 3
Detroit 3
Frattamaggiore 3
Hanover 3
Maywood 3
Menlo Park 3
Norman 3
Oklahoma City 3
Pomigliano D'arco 3
Povegliano Veronese 3
Redmond 3
Shanghai 3
Vietri Sul Mare 3
Atella 2
Birmingham 2
Buffalo 2
Cuauhtémoc 2
Easton 2
Eboli 2
Ercolano 2
Freyburg 2
Fucecchio 2
Gaeta 2
Genova 2
Haikou 2
Leawood 2
Madrid 2
Marigliano 2
Monteforte Irpino 2
New York 2
Ningbo 2
Nürnberg 2
San Jose 2
Sant'antimo 2
Solna 2
Sorrento 2
Totale 17468
Nome #
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 140
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 136
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 131
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 113
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 109
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 107
The natural history of multiple system atrophy: A prospective European cohort study 103
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 102
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 101
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 99
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 98
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 97
Increased bilirubin levels in de novo Parkinson's disease 95
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 95
Normative data for the Montreal Cognitive Assessment in an Italian population sample 94
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 93
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 90
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 89
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 89
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 88
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 88
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 87
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 87
Affective theory of mind in patients with Parkinson's disease: comment 87
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 86
D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. 84
Malabsorption is uncommon in restless legs syndrome. 83
Aiming for study comparability in Parkinson's disease: Proposal for a modular set of biomarker assessments to be used in longitudinal studies 82
The accuracy of the arginine growth hormone test in parkinsonism. 79
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Aug 15;23(11):1532-40.PMID: 18581467 79
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 79
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 79
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. 78
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 78
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 78
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 78
Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study 78
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 78
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? 77
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 76
Gender and non motor fluctuations in Parkinson's disease: A prospective study 76
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 76
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 75
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Oct;16(10):1090-9. Review.PMID: 19723294 75
Diagnosis and management of Parkinson's disease dementia. Oct;62(10):1581-7. Review.PMID: 18822028 75
Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide 75
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 75
The alpha-synuclein gene in multiple system atrophy 74
Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors. 74
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 73
Nitric oxide-haemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI. 73
Apathy and related executive syndromes in dementia associated with Parkinson's disease and in Alzheimer's disease 73
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 73
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease 73
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 73
Plasma prolactin response to sodium valproate in epileptic patients 72
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 72
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 72
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease 72
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study 72
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 72
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. 71
Pramipexole in patients with early Parkinson's disease (PROUD): A randomised delayed-start trial 71
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 71
Inhibition of septal hyperreactivity by testosterone and its reversion by an estrogen antagonist in weanling female rats 71
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. 70
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 70
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 69
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 69
Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. 69
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 69
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD 69
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 69
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 69
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 68
Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade. 68
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 68
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 68
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 68
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 68
The relevance of gender in Parkinson's disease: a review 67
Quitting smoking: An early non-motor feature of Parkinson's disease? 67
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease. 67
Letter by Moccia et al regarding article, "archetypal Arg169Cys Mutation in NOTCH3 Does Not Drive the Pathogenesis in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy via a Loss-of-Function Mechanism" 67
Apathy in Parkinson's disease: Diagnosis, neuropsychological correlates, pathophysiology and treatment 67
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 67
D-1 dopamine receptor changes after striatal quinolinic acid lesion. 66
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 66
Season of birth and Parkinson’s disease: possible relationship? 66
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 66
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 66
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 66
D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models andparkinsonian patients. 65
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 65
Teaching Video Neuro Images: Finger clonus 65
Paradoxical response to apomorphine in a case of atypical parkinsonism 64
Wine drinking and essential tremor: a possible protective role. 64
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 64
Cortical thickness in Parkinsonians with impulse control disorders: A comment 64
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease 64
Totale 7863
Categoria #
all - tutte 34434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34434

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181605 0000 00 0558 26142036330
2018/20192668 186145118176 177485 167231 21515455460
2019/20203211 9849636526 23953 31428 28023754445
2020/20212639 2424827010 363134 34219 30522340562
2021/20222600 1441425 2316 40111 4033663541230
2022/20232789 47117497358 655934 2476 0000
Totale 21360